METTL3:一种多功能疾病调节剂.
1Division of Cardiothoracic and Vascular Surgery, Sino-Swiss Heart-Lung Transplantation Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Molecular and cellular biochemistry
|January 24, 2025
概括
由甲基转移酶类3 (METTL3) 调节的N6-甲基氨酸 (m6A) 甲基化在各种疾病中起着关键作用. 作为一种治疗标和诊断生物标志物,METTL3对癌症和代谢障碍等疾病具有前景.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 在RNA生物学,RNA生物学.
背景情况:
- N6-甲基氨酸 (m6A) 是最丰富的内部mRNA修饰,对基因调节至关重要.
- 甲基转移酶类3 (METTL3) 是主要催化甲基化的酶.
- 异常METTL3表达与许多病理状况有关,包括代谢疾病,心血管疾病和癌症.
研究的目的:
- 审查METTL3在各种疾病中的调控功能.
- 突出最近在识别METTL3下游目标基因和分子机制方面的进展.
- 讨论METTL3作为治疗标和诊断生物标记物的潜力.
主要方法:
- 关于METTL3功能和调节的最新研究的文献综述.
- 分析METTL3在代谢疾病,心血管疾病和癌症中的作用.
- 检查METTL3表达和活性的分子机制和调节剂.
主要成果:
- 在多种疾病系统中,METTL3 调节了多种功能基因.
- METTL3的甲基转移酶活性和mRNA的翻译后修改是其调节机制的关键.
- METTL3与代谢性疾病,心血管疾病和癌症的发病有关.
结论:
- METTL3是一种多功能调节剂,在各种疾病中起着重要作用.
- 了解METTL3的下游目标和监管机制对于治疗开发至关重要.
- 作为一种新的诊断生物标志物和治疗点,METTL3具有相当大的潜力.
相关概念视频
02:23Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
02:04Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K